Well being expertise firm Tempus AI, established by the Groupon founder and billionaire Eric Lefkofsky, was named as a nominal defendant in a shareholder by-product lawsuit filed towards a number of firm executives in Illinois federal court docket this week. The plaintiff claims the corporate overstated its synthetic intelligence (AI) capabilities and embellished the worth of its contracts with companions, like AstraZeneca and Pathos AI, the grievance mentioned.
Trending
- ‘My fasting glucose is 103.3 mg/dL and HbA1c is 4.84 per cent. Should I be worried?’ | Health News
- YouTube Shares Tips for Maximizing Podcast Engagement
- 71% of People Support Social Media Bans for Children [Infographic]
- Report Suggests That Posting More Often Increases TikTok Performance
- Creators Are Drawing Big Crowds With IRL Events [Infographic]
- 36 Predictions for Social Media Marketing in 2026
- When your hinge date is the mayoral front-runner | Feelings News
- ‘Morning people are more productive than night people,’ say Akshay Kumar-Twinkle Khanna while Saif Ali Khan-Kajol ‘heartily disagree’ | Health News
Monday, October 13
AI-Backed Healthcare Company Hit with Shareholder Derivative Suit
